The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Voyager Therapeutics Inc’s current trading price is -59.52% away from its 52-week high, while its distance from the 52-week low is 26.65%. The stock’s price range for this period has been between $2.64 and $8.27 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 0.55 million for the day, a number notably lower than the average daily volume of 0.78 million over the last three months.
The present stock price for Voyager Therapeutics Inc (VYGR) is $3.35. In the last trading session, the stock made a considerable jump, reaching $30.0 after an opening price of $3.35. The stock briefly fell to $8.0 before ending the session at $3.56.
Voyager Therapeutics Inc saw a rather unpredictable run in, in terms of market performance. The company’s stock reached its highest point at $8.27 on 10/18/24, while the lowest price for the same duration was marked at $2.64 on 05/30/25.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Voyager Therapeutics Inc (VYGR) has experienced a quarterly decline of -1.47% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 185.82M and boasts a workforce of 172 employees.
Voyager Therapeutics Inc: What Analysts Are Saying
As of right now, 11 analysts are rating Voyager Therapeutics Inc as a BUY, 1 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 3.26, with a change in price of -0.39. Similarly, Voyager Therapeutics Inc recorded 627,051 in trading volume during the last 100 days, posting a change of -10.43%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for VYGR stands at 0.16. Similarly, the long-term debt-to-equity ratio is also 0.13.
VYGR Stock Stochastic Average
As of today, Voyager Therapeutics Inc’s raw stochastic average for the last 50 days stands at 48.60%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 45.88%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 68.84% and 80.19%, respectively.
VYGR Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The index has shown a price loss of -48.22% this year. Over the last six months, there has been a stronger performance of -22.09%. The price of VYGR fallen by 6.01% during the last 30 days period. For the last 5-days stocks have slided -8.22%.
